Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement

Radiology

Volumn 225, Issue 2, 2002, Pages 527-536

  Michel, Sven C A ^a   Keller, Thomas M ^a   Fröhlich, Johannes M ^a   Fink, Daniel ^a   Caduff, Rosmarie ^a   Seifert, Burkhardt ^a   Marincek, Borut ^a   Kubik Huch, Rahel A ^a  

^a Kantonsspital Baden   (Switzerland)

Author keywords

Breast neoplasms, metastases; Breast neoplasms, MR; Contrast media, comparative studies; Iron; Lymphatic system, MR; Lymphatic system, neoplasms; Magnetic resonance (MR), contrast enhancement

Indexed keywords

GADOLINIUM PENTETATE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ABDOMINAL PAIN; ADULT; AGED; APPARATUS; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER STAGING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG RESPONSE; EVALUATION; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; LOW BACK PAIN; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PRURITUS; RASH; SENSITIVITY AND SPECIFICITY; STANDARD; THORAX PAIN;

EID: 0036830142     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2252011605     Document Type: Article

References (47)

1. Gilbert FJ. New screening techniques for breast cancer (MRI). Dis Markers 1999; 15:115-116.
2. Friedrich M. MRI of the breast: State of the art. Eur Radiol 1998; 8:707-725.
3. Fischer U, Kopka L, Grabbe E. Breast carcinoma: Effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999; 213:881-888.
4. Morrow M. Role of axillary dissection in breast cancer management. Ann Surg Oncol 1996; 3:233-234.
5. Pressman PI. Surgical treatment and lymphedema. Cancer 1998; 83(12 suppl American):2782-2787.
6. Noguchi M, Kurosumi M, Iwata H, et al. Clinical and pathologic factors predicting axillary lymph node involvement in breast cancer. Breast Cancer 2000; 7:114-123.
7. Yeoh EK, Denham JW, Davies SA, Spittle MF. Primary breast cancer: Complications of axillary management. Acta Radiol Oncol 1986; 25:105-108.
8. Silverstein MJ, Skinner KA, Lomis TJ. Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg 2001; 25:767-772.
9. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220:391-398.
10. Kuhn T, Santjohanser C, Koretz K, Bohm W, Kreienberg R. Axilloscopy and endoscopic sentinel node detection in breast cancer patients. Surg Endosc 2000; 14: 573-577.
11. Kuehn T, Santjohanser C, Grab D, Klauss W, Koretz K, Kreienberg R. Endoscopic axillary surgery in breast cancer. Br J Surg 2001; 88:698-703.
12. Malur S, Bechler J, Schneider A. Endoscopic axillary lymphadenectomy without prior liposuction in 100 patients with invasive breast cancer. Surg Laparosc Endosc Percutan Tech 2001; 11:38-41.
13. Aapro MS. Neoadjuvant therapy in breast cancer: Can we define its role? Oncologist 2001; 6(suppl 3):36-39.
14. Anzai Y, Blackwell KE, Hirschowitz SL, et al. Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer. Radiology 1994; 192:709-715.
15. Bellin MF, Roy C, Kinkel K, et al. Lymph node metastases: Safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles - Initial clinical experience. Radiology 1998; 207: 799-808A.
16. Bellin MF, Beigelman C, Precetti-Morel S. Iron oxide-enhanced MR lymphography: Initial experience. Eur J Radiol 2000; 34: 257-264.
17. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L. Ultrasmall superparamagnetic iron oxide: Characterization of a new class of contrast agents for MR imaging. Radiology 1990; 175:489-493.
18. Anzai Y, McLachlan S, Morris M, Saxton R, Lufkin RB. Dextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck. AJNR Am J Neuroradiol 1994; 1:5:87-94.
19. Anzai Y, Prince MR. Iron oxide-enhanced MR lymphography: The evaluation of cervical lymph node metastases in head and neck cancer. J Magn Reson Imaging 1997; 7:75-81.
20. Harisinghani MG, Saini S, Slater GJ, Schnall MD, Rifkin MD. MR imaging of pelvic lymph nodes in primary pelvic carcinoma with ultrasmall superparamagnetic iron oxide (Combidex): Preliminary observations. J Magn Reson Imaging 1997; 7:161-163.
21. Kvistad KA, Rydland J, Smethurst HB, Lundgren S, Fjosne HE, Haraldseth O. Axillary lymph node metastases in breast cancer: Preoperative detection with dynamic contrast-enhanced MRI. Eur Radiol 2000; 10:1464-1471.
22. Yang WT, Lam WW, Yu MY, Cheung TH, Metreweli C. Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. AJR Am J Roentgenol 2000; 175:759-766.
23. Uematsu T, Sano M, Homma K. In vitro high-resolution helical CT of small axillary lymph nodes in patients with breast cancer: Correlation of CT and histology. AJR Am J Roentgenol 2001; 176:1069-1074.
24. Vasallo JL, Arreaza R, Munoz-Barragan L. Immunocytochemical study of vasopressin-like immunoreactive material in the gastrointestinal tract of the hedgehog Erinanceus europeus. Bol Asoc Med P R 1992; 84:67-69.
25. Landis JR, Koch GG. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977; 33: 363-374.
26. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33:159-174.
27. Loubeyre P, Zhao S, Canet E, Abidi H, Benderbous S, Revel D. Ultrasmall superparamagnetic iron oxide particles (AMI 227) as a blood pool contrast agent for MR angiography: Experimental study in rabbits. J Magn Reson Imaging 1997; 7:958-962.
28. Engelbrecht MR, Saeed M, Wendland MF, Canet E, Oksendal AN, Higgins CB. Contrast-enhanced 3D-TOF MRA of peripheral vessels: Intravascular versus extracellular MR contrast media. J Magn Reson Imaging 1998; 8:616-621.
29. Daldrup HE, Link TM, Blasius S, et al. Monitoring radiation-induced changes in bone marrow histopathology with ultrasmall superparamagnetic iron oxide (USPIO)-enhanced MRI. J Magn Reson Imaging 1999; 9:643-652.
30. Schwickert HC, Stiskal M, Roberts TP, et al. Contrast-enhanced MR imaging assessment of tumor capillary permeability: Effect of irradiation on delivery of chemotherapy. Radiology 1996; 198:893-898.
31. Turetschek K, Huber S, Floyd E, et al. MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation. Radiology 2001; 218:562-569.
32. Tsuboi N, Ogawa Y, Inomata T, et al. Changes in the findings of dynamic MRI by preoperative CAF chemotherapy for patients with breast cancer of stage II and III: Pathologic correlation. Oncol Rep 1999; 6:727-732.
33. Moll UM, Chumas J. Morphologic effects of neoadjuvant chemotherapy in locally advanced breast cancer. Pathol Res Pract 1997; 193:187-196.
34. Rieber A, Zeitler H, Rosenthal H, et al. MRI of breast cancer: Influence of chemotherapy on sensitivity. Br J Radiol 1997; 70:452-458.
35. Vinnicombe SJ, MacVicar AD, Guy RL, et al. Primary breast cancer: Mammographic changes after neoadjuvant chemotherapy, with pathologic correlation. Radiology 1996; 198:333-340.
36. Veronesi U, Luini A, Galimberti V, Marchini S, Sacchini V, Rilke F. Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur J Surg Oncol 1990; 16:127-133.
37. Paganelli G. Sentinel node biopsy: Role of nuclear medicine in conservative surgery of breast cancer. Eur J Nucl Med 1998; 25:99-100.
38. Lee AS, Weissleder R, Brady TJ, Wittenberg J. Lymph nodes: Microstructural anatomy at MR imaging. Radiology 1991; 178:519-522.
39. Dooms GC, Hricak H, Moseley ME, Bottles K, Fisher M, Higgins CB. Characterization of lymphadenopathy by magnetic resonance relaxation times: Preliminary results. Radiology 1985; 155:691-697.
40. Wiener JI, Chako AC, Merten CW, Gross S, Coffey EL, Stein HL. Breast and axillary tissue MR imaging: Correlation of signal intensities and relaxation times with pathologic findings. Radiology 1986; 160: 299-305.
41. Glazer GM, Orringer MB, Chenevert TL, et al. Mediastinal lymph nodes: Relaxation time/pathologic correlation and implications in staging of lung cancer with MR imaging. Radiology 1988; 168: 429-431.
42. Mumtaz H, Hall-Craggs MA, Davidson T, et al. Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol 1997; 169:417-424.
43. Attiyeh FF, Jensen M, Huvos AG, Fracchia A. Axillary micrometastasis and macrometastasis in carcinoma of the breast. Surg Gynecol Obstet 1977; 144:839-842.
44. Hartveit F, Lilleng PK. Breast cancer: Two micrometastatic variants in the axilla that differ in prognosis. Histopathology 1996; 28:241-246.
45. Lilleng PK, Maehle BO, Hartveit F. The size of a micrometastasis in the axilla in breast cancer: A study of nodal tumor-load related to prognosis. Eur J Gynaecol Oncol 1998; 19:220-224.
46. Hoda SA, Chiu A, Prasad ML, Giri D, Hoda RS. Are microinvasion and micrometastasis in breast cancer mountains or molehills? Am J Surg 2000; 180:305-308.
47. Leong AS. The prognostic dilemma of nodal micrometastases in breast carcinoma. Gan To Kagaku Ryoho 2000; 27(suppl 2):315-320.